CRI Lifetree has opened a new, 21,000-sq.-ft. early stage research facility in Marlton, NJ, bringing the company’s total bed count to 250 and adding capacity to conduct complex clinical trials.
 
Additional capabilities allow for conducting complex neurology, pediatrics and normal healthy patient studies. Other facility features include six beds dedicated to first-in-human studies, an observation area providing access to clinicians and sponsors, and separate areas for elderly and pediatric populations. CRI Lifetree has two other facilities in Philadelphia and Salt Lake City.